Menstrual cycle associated changes in hormone-related gene expression in oestrogen receptor positive breast cancer
Abstract The major changes in hormone levels that occur through the menstrual cycle have been postulated to affect the expression of hormone-regulated and proliferation-associated genes (PAGs) in premenopausal ER+ breast cancer. Whilst previous studies have demonstrated differences in gene expressio...
Saved in:
Published in | NPJ breast cancer Vol. 5; no. 1; pp. 1 - 11 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group
15.11.2019
Nature Publishing Group UK |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
The major changes in hormone levels that occur through the menstrual cycle have been postulated to affect the expression of hormone-regulated and proliferation-associated genes (PAGs) in premenopausal ER+ breast cancer. Whilst previous studies have demonstrated differences in gene expression, here, we investigated if there are within patient changes in the expression of oestrogen- and progesterone-regulated genes (ERGs and PRGs) and PAGs in ER+ breast cancer during the menstrual cycle. Samples from 96 patients in two independent prospective studies of the effect of menstrual cycle on ER+ breast cancer were used. Plasma hormone measurements were used to assign tumours to one of three pre-defined menstrual cycle windows: W1 (days 27–35 and 1–6; low oestradiol and low progesterone), W2 (days 7–16; high oestradiol and low progesterone) and W3 (days 17–26; intermediate oestradiol and high progesterone). RNA expression of 50 genes, including 27 ERGs, 11 putative PRGs and seven PAGs was measured. The AvERG (geomean of
PGR
,
GREB1
,
TFF1
and
PDZK1
) was used as a composite measure of ERG expression and showed significant changes between the three windows of the menstrual cycle increasing over 2.2-fold between W1 and W2 and decreasing between W2 and W3 and between W3 and W1. Proliferation gene expression also varied significantly, following the same pattern of changes as ERG expression, but the changes were of lower magnitude (1.4-fold increase between W1 and W2). Significant changes in the expression of eight individual ERGs, including
GREB1
,
PGR
and
TFF1
, and two PAGs were observed between W1 and either W2 or W3 with all genes showing higher levels in W2 or W3 (1.3–2.4-fold; FDR 0.016–0.05). The AvProg, a composite measure of PRG expression, increased significantly (1.5-fold) in W3 compared to W1 or W2 but no significant changes were observed for individual PRGs. In conclusion, we observed significant changes in ERG, PRG and PAG expression in ER+ breast tumours during the menstrual cycle that may affect the assessment and interpretation of prominent biomarkers (e.g. PgR) and commonly used multigene prognostic signatures in premenopausal ER+ breast cancer. |
---|---|
AbstractList | The major changes in hormone levels that occur through the menstrual cycle have been postulated to affect the expression of hormone-regulated and proliferation-associated genes (PAGs) in premenopausal ER+ breast cancer. Whilst previous studies have demonstrated differences in gene expression, here, we investigated if there are within patient changes in the expression of oestrogen- and progesterone-regulated genes (ERGs and PRGs) and PAGs in ER+ breast cancer during the menstrual cycle. Samples from 96 patients in two independent prospective studies of the effect of menstrual cycle on ER+ breast cancer were used. Plasma hormone measurements were used to assign tumours to one of three pre-defined menstrual cycle windows: W1 (days 27–35 and 1–6; low oestradiol and low progesterone), W2 (days 7–16; high oestradiol and low progesterone) and W3 (days 17–26; intermediate oestradiol and high progesterone). RNA expression of 50 genes, including 27 ERGs, 11 putative PRGs and seven PAGs was measured. The AvERG (geomean of
PGR
,
GREB1
,
TFF1
and
PDZK1
) was used as a composite measure of ERG expression and showed significant changes between the three windows of the menstrual cycle increasing over 2.2-fold between W1 and W2 and decreasing between W2 and W3 and between W3 and W1. Proliferation gene expression also varied significantly, following the same pattern of changes as ERG expression, but the changes were of lower magnitude (1.4-fold increase between W1 and W2). Significant changes in the expression of eight individual ERGs, including
GREB1
,
PGR
and
TFF1
, and two PAGs were observed between W1 and either W2 or W3 with all genes showing higher levels in W2 or W3 (1.3–2.4-fold; FDR 0.016–0.05). The AvProg, a composite measure of PRG expression, increased significantly (1.5-fold) in W3 compared to W1 or W2 but no significant changes were observed for individual PRGs. In conclusion, we observed significant changes in ERG, PRG and PAG expression in ER+ breast tumours during the menstrual cycle that may affect the assessment and interpretation of prominent biomarkers (e.g. PgR) and commonly used multigene prognostic signatures in premenopausal ER+ breast cancer. Abstract The major changes in hormone levels that occur through the menstrual cycle have been postulated to affect the expression of hormone-regulated and proliferation-associated genes (PAGs) in premenopausal ER+ breast cancer. Whilst previous studies have demonstrated differences in gene expression, here, we investigated if there are within patient changes in the expression of oestrogen- and progesterone-regulated genes (ERGs and PRGs) and PAGs in ER+ breast cancer during the menstrual cycle. Samples from 96 patients in two independent prospective studies of the effect of menstrual cycle on ER+ breast cancer were used. Plasma hormone measurements were used to assign tumours to one of three pre-defined menstrual cycle windows: W1 (days 27–35 and 1–6; low oestradiol and low progesterone), W2 (days 7–16; high oestradiol and low progesterone) and W3 (days 17–26; intermediate oestradiol and high progesterone). RNA expression of 50 genes, including 27 ERGs, 11 putative PRGs and seven PAGs was measured. The AvERG (geomean of PGR , GREB1 , TFF1 and PDZK1 ) was used as a composite measure of ERG expression and showed significant changes between the three windows of the menstrual cycle increasing over 2.2-fold between W1 and W2 and decreasing between W2 and W3 and between W3 and W1. Proliferation gene expression also varied significantly, following the same pattern of changes as ERG expression, but the changes were of lower magnitude (1.4-fold increase between W1 and W2). Significant changes in the expression of eight individual ERGs, including GREB1 , PGR and TFF1 , and two PAGs were observed between W1 and either W2 or W3 with all genes showing higher levels in W2 or W3 (1.3–2.4-fold; FDR 0.016–0.05). The AvProg, a composite measure of PRG expression, increased significantly (1.5-fold) in W3 compared to W1 or W2 but no significant changes were observed for individual PRGs. In conclusion, we observed significant changes in ERG, PRG and PAG expression in ER+ breast tumours during the menstrual cycle that may affect the assessment and interpretation of prominent biomarkers (e.g. PgR) and commonly used multigene prognostic signatures in premenopausal ER+ breast cancer. The major changes in hormone levels that occur through the menstrual cycle have been postulated to affect the expression of hormone-regulated and proliferation-associated genes (PAGs) in premenopausal ER+ breast cancer. Whilst previous studies have demonstrated differences in gene expression, here, we investigated if there are within patient changes in the expression of oestrogen- and progesterone-regulated genes (ERGs and PRGs) and PAGs in ER+ breast cancer during the menstrual cycle. Samples from 96 patients in two independent prospective studies of the effect of menstrual cycle on ER+ breast cancer were used. Plasma hormone measurements were used to assign tumours to one of three pre-defined menstrual cycle windows: W1 (days 27–35 and 1–6; low oestradiol and low progesterone), W2 (days 7–16; high oestradiol and low progesterone) and W3 (days 17–26; intermediate oestradiol and high progesterone). RNA expression of 50 genes, including 27 ERGs, 11 putative PRGs and seven PAGs was measured. The AvERG (geomean of PGR, GREB1, TFF1 and PDZK1) was used as a composite measure of ERG expression and showed significant changes between the three windows of the menstrual cycle increasing over 2.2-fold between W1 and W2 and decreasing between W2 and W3 and between W3 and W1. Proliferation gene expression also varied significantly, following the same pattern of changes as ERG expression, but the changes were of lower magnitude (1.4-fold increase between W1 and W2). Significant changes in the expression of eight individual ERGs, including GREB1, PGR and TFF1, and two PAGs were observed between W1 and either W2 or W3 with all genes showing higher levels in W2 or W3 (1.3–2.4-fold; FDR 0.016–0.05). The AvProg, a composite measure of PRG expression, increased significantly (1.5-fold) in W3 compared to W1 or W2 but no significant changes were observed for individual PRGs. In conclusion, we observed significant changes in ERG, PRG and PAG expression in ER+ breast tumours during the menstrual cycle that may affect the assessment and interpretation of prominent biomarkers (e.g. PgR) and commonly used multigene prognostic signatures in premenopausal ER+ breast cancer. |
ArticleNumber | 42 |
Author | Laws, Siobhan To, Ta Van Dowsett, Mitch Thi Han, Pham Dinh, Nguyen Van Afentakis, Maria Khoa, Pham Hong Holcombe, Chris Gao, Qiong Folkerd, Elizabeth Sibbering, Mark Buus, Richard Skene, Anthony Osborne, Caroline Quang, Le Hong Ginsburg, Ophira Evans, Abigail Haynes, Ben P. Clemons, Mark Rogers, Clare Smith, Ian E. Noor, Lubna |
Author_xml | – sequence: 1 givenname: Ben P. surname: Haynes fullname: Haynes, Ben P. – sequence: 2 givenname: Ophira orcidid: 0000-0002-1384-2675 surname: Ginsburg fullname: Ginsburg, Ophira – sequence: 3 givenname: Qiong orcidid: 0000-0002-0406-1594 surname: Gao fullname: Gao, Qiong – sequence: 4 givenname: Elizabeth surname: Folkerd fullname: Folkerd, Elizabeth – sequence: 5 givenname: Maria surname: Afentakis fullname: Afentakis, Maria – sequence: 6 givenname: Richard orcidid: 0000-0002-3386-3465 surname: Buus fullname: Buus, Richard – sequence: 7 givenname: Le Hong surname: Quang fullname: Quang, Le Hong – sequence: 8 givenname: Pham surname: Thi Han fullname: Thi Han, Pham – sequence: 9 givenname: Pham Hong surname: Khoa fullname: Khoa, Pham Hong – sequence: 10 givenname: Nguyen Van orcidid: 0000-0002-9614-4628 surname: Dinh fullname: Dinh, Nguyen Van – sequence: 11 givenname: Ta Van surname: To fullname: To, Ta Van – sequence: 12 givenname: Mark surname: Clemons fullname: Clemons, Mark – sequence: 13 givenname: Chris surname: Holcombe fullname: Holcombe, Chris – sequence: 14 givenname: Caroline surname: Osborne fullname: Osborne, Caroline – sequence: 15 givenname: Abigail surname: Evans fullname: Evans, Abigail – sequence: 16 givenname: Anthony surname: Skene fullname: Skene, Anthony – sequence: 17 givenname: Mark surname: Sibbering fullname: Sibbering, Mark – sequence: 18 givenname: Clare surname: Rogers fullname: Rogers, Clare – sequence: 19 givenname: Siobhan surname: Laws fullname: Laws, Siobhan – sequence: 20 givenname: Lubna surname: Noor fullname: Noor, Lubna – sequence: 21 givenname: Ian E. surname: Smith fullname: Smith, Ian E. – sequence: 22 givenname: Mitch orcidid: 0000-0003-4122-744X surname: Dowsett fullname: Dowsett, Mitch |
BookMark | eNpdkU9r3DAQxUVJadJtPkBvgl5ycau_lnUJhJC0hZRe2rOYyONdBa_kSHZovn3kbghpBUID76c3Gr335CimiIR85OwzZ7L7UhTXQjaM27pl14g35ERIoxrVGnP0qj4mp6XcMca4ajur-TtyLLnRqhXmhOQfGMucFxipf_QjUigl-QAz9tTvIG6x0BDpLuV9bd9kHP9KW4xI8c-UsZSQ4ookrD6pCjSjx2lOmU6phDk8IL3NCGWmHqLH_IG8HWAsePp8bsjv66tfl9-am59fv19e3DReMTU3yg9KtlIbMNqC1QP0nBnbG8aE8F6oXkrGul6h8lxYRLDcyEFrCcDMwOSGnB98p-V2j73HOGcY3ZTDHvKjSxDcv0oMO7dND67tdCfr2pCzZ4Oc7pc6ntuH4nEcIWJaihPrN1qt7Nrr03_oXVpyrOOtlDKtYbytFD9QPqdSMg4vj-HMraG6Q6iuhurWUOvlJxg3lvo |
CitedBy_id | crossref_primary_10_1016_j_coemr_2020_11_001 crossref_primary_10_1007_s10549_021_06254_z crossref_primary_10_1186_s12885_021_08496_y crossref_primary_10_1186_s13058_020_01327_1 crossref_primary_10_1007_s10549_021_06336_y crossref_primary_10_1177_17588359221081077 crossref_primary_10_1007_s10549_021_06377_3 crossref_primary_10_26416_Med_140_2_2021_4929 crossref_primary_10_1007_s10549_023_07087_8 crossref_primary_10_3233_BSI_230000 |
Cites_doi | 10.1007/BF02303669 10.1038/nbt1385 10.1007/s10549-014-3181-6 10.1200/JCO.2005.07.559 10.6084/m9.figshare.9892211 10.1200/JCO.2009.23.9616 10.1126/sciadv.1501924 10.1002/(SICI)1097-0142(19980815)83:4<698::AID-CNCR10>3.0.CO;2-N 10.1038/s41523-017-0049-z 10.1038/nature09495 10.1210/jc.2005-2378 10.1007/s10549-009-0523-x 10.1093/jnci/djn309 10.1093/jnci/djk020 10.1007/s10549-012-2164-8 10.1186/s13058-016-0696-2 10.1093/jncics/pky005 10.1093/jnci/92.11.903 10.1016/S0140-6736(97)07498-9 10.1158/0008-5472.CAN-11-3290 10.1093/annonc/mdg258 10.1126/scitranslmed.3005654 10.1016/j.mce.2005.01.009 10.1007/s10549-014-3049-9 10.1136/jcp.2010.077578 10.1002/1097-0142(20010515)91:10<1854::AID-CNCR1206>3.0.CO;2-Y 10.1007/s10549-013-2426-0 10.1038/bjc.2011.145 10.1016/0006-291X(87)91022-9 10.1056/NEJMoa041588 10.1186/s13058-016-0713-5 10.1093/jjco/hyy156 10.1038/nature14583 10.1200/JCO.2005.04.005 10.1074/jbc.M110090200 10.1210/mend.15.4.0616 10.1200/JCO.2008.18.1370 10.1007/s10549-008-0003-8 10.1002/cjp2.112 10.1186/bcr2124 10.1002/ijc.21186 10.1073/pnas.080073497 10.1158/1078-0432.CCR-11-0926 10.1007/s10549-008-9949-9 10.1016/0014-5793(84)80766-8 |
ContentType | Journal Article |
Copyright | 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2019 |
Copyright_xml | – notice: 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2019 |
DBID | AAYXX CITATION 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1038/s41523-019-0138-2 |
DatabaseName | CrossRef ProQuest Central (Corporate) ProQuest_Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2374-4677 |
EndPage | 11 |
ExternalDocumentID | 10_1038_s41523_019_0138_2 |
GrantInformation_xml | – fundername: ; grantid: BCRF-18-040; BCRF-18-040; BCRF-18-040 |
GroupedDBID | 0R~ 3V. 53G 5VS 7X7 8FI 8FJ AAJSJ AAYXX ABUWG ACGFS ACSMW ADBBV AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BCNDV BENPR BPHCQ BVXVI C6C CCPQU CITATION EBLON EBS EJD EMOBN FYUFA GROUPED_DOAJ HMCUK HYE M~E NAO NO~ OK1 PGMZT PIMPY PQQKQ PROAC RNT RPM SNYQT UKHRP 7XB 8FK AZQEC DWQXO K9. PQEST PQUKI PRINS 7X8 AFGXO 5PM |
ID | FETCH-LOGICAL-c404t-4cf436357a759a95fad1079d70022cc24d33008d4e4c129eea9173f553aa07f03 |
IEDL.DBID | RPM |
ISSN | 2374-4677 |
IngestDate | Tue Sep 17 21:26:38 EDT 2024 Fri Aug 16 03:08:37 EDT 2024 Fri Sep 13 08:45:47 EDT 2024 Fri Aug 23 02:40:27 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c404t-4cf436357a759a95fad1079d70022cc24d33008d4e4c129eea9173f553aa07f03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-4122-744X 0000-0002-3386-3465 0000-0002-1384-2675 0000-0002-0406-1594 0000-0002-9614-4628 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858333/ |
PMID | 31754627 |
PQID | 2314767016 |
PQPubID | 2041925 |
PageCount | 11 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6858333 proquest_miscellaneous_2317595490 proquest_journals_2314767016 crossref_primary_10_1038_s41523_019_0138_2 |
PublicationCentury | 2000 |
PublicationDate | 2019-11-15 |
PublicationDateYYYYMMDD | 2019-11-15 |
PublicationDate_xml | – month: 11 year: 2019 text: 2019-11-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London |
PublicationTitle | NPJ breast cancer |
PublicationYear | 2019 |
Publisher | Nature Publishing Group Nature Publishing Group UK |
Publisher_xml | – name: Nature Publishing Group – name: Nature Publishing Group UK |
References | A Dodson (138_CR1) 2018; 4 C Atalay (138_CR23) 2002; 49 H Mohammed (138_CR26) 2015; 523 L Zabaglo (138_CR42) 2010; 63 Y Liang (138_CR29) 2007; 67 M Vasei (138_CR22) 2006; 9 BP Haynes (138_CR10) 2014; 148 P Pujol (138_CR18) 1998; 83 AK Dunbier (138_CR8) 2010; 28 RL Robker (138_CR44) 2000; 97 M Filipits (138_CR13) 2011; 17 E López-Knowles (138_CR15) 2016; 18 S Purmonen (138_CR46) 2008; 19 OC Freedman (138_CR5) 2010; 119 M Dowsett (138_CR3) 2007; 99 MG Jannuzzo (138_CR7) 2009; 11 A Mangia (138_CR20) 1998; 17 P Wirapati (138_CR38) 2008; 10 JS Parker (138_CR12) 2009; 27 Y Wanifuchi-Endo (138_CR32) 2019; 49 H Hu (138_CR37) 2014; 146 PL Jerevall (138_CR14) 2011; 104 D Coradini (138_CR21) 2003; 14 JG Klijn (138_CR6) 2000; 92 H Singhal (138_CR27) 2016; 2 P Pujol (138_CR24) 2001; 91 I Smith (138_CR2) 2005; 23 T Tanos (138_CR35) 2013; 5 M Dowsett (138_CR41) 2005; 23 JC Leo (138_CR47) 2005; 117 SA Khan (138_CR19) 1997; 4 S Paik (138_CR11) 2004; 351 S Mrusek (138_CR48) 2005; 235 MJ Ellis (138_CR4) 2008; 100 BP Haynes (138_CR17) 2017; 3 NG Seidah (138_CR34) 1984; 175 BP Haynes (138_CR9) 2013; 138 Z Saad (138_CR25) 1998; 351 S Giulianelli (138_CR30) 2012; 72 SC Chapman (138_CR33) 2001; 15 CE Wood (138_CR45) 2009; 114 JS Lee (138_CR40) 2006; 91 JK Richer (138_CR43) 2002; 277 N Simigdala (138_CR39) 2016; 18 138_CR50 GK Geiss (138_CR49) 2008; 26 JR Hissom (138_CR28) 1987; 145 E Gonzalez-Suarez (138_CR36) 2010; 468 Q Gao (138_CR16) 2018; 2 P Kabos (138_CR31) 2012; 135 |
References_xml | – volume: 4 start-page: 462 year: 1997 ident: 138_CR19 publication-title: Ann. Surg. Oncol. doi: 10.1007/BF02303669 contributor: fullname: SA Khan – volume: 26 start-page: 317 year: 2008 ident: 138_CR49 publication-title: Nat. Biotechnol. doi: 10.1038/nbt1385 contributor: fullname: GK Geiss – volume: 148 start-page: 327 year: 2014 ident: 138_CR10 publication-title: Breast Cancer Res. Treat. doi: 10.1007/s10549-014-3181-6 contributor: fullname: BP Haynes – volume: 67 start-page: 929 year: 2007 ident: 138_CR29 publication-title: Cancer Res. contributor: fullname: Y Liang – volume: 23 start-page: 2477 year: 2005 ident: 138_CR41 publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2005.07.559 contributor: fullname: M Dowsett – ident: 138_CR50 doi: 10.6084/m9.figshare.9892211 – volume: 28 start-page: 1161 year: 2010 ident: 138_CR8 publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2009.23.9616 contributor: fullname: AK Dunbier – volume: 2 year: 2016 ident: 138_CR27 publication-title: Sci. Adv. doi: 10.1126/sciadv.1501924 contributor: fullname: H Singhal – volume: 83 start-page: 698 year: 1998 ident: 138_CR18 publication-title: Cancer doi: 10.1002/(SICI)1097-0142(19980815)83:4<698::AID-CNCR10>3.0.CO;2-N contributor: fullname: P Pujol – volume: 3 year: 2017 ident: 138_CR17 publication-title: NPJ Breast Cancer doi: 10.1038/s41523-017-0049-z contributor: fullname: BP Haynes – volume: 468 start-page: 103 year: 2010 ident: 138_CR36 publication-title: Nature doi: 10.1038/nature09495 contributor: fullname: E Gonzalez-Suarez – volume: 91 start-page: 3791 year: 2006 ident: 138_CR40 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2005-2378 contributor: fullname: JS Lee – volume: 19 start-page: 1627 year: 2008 ident: 138_CR46 publication-title: Oncol. Rep. contributor: fullname: S Purmonen – volume: 119 start-page: 155 year: 2010 ident: 138_CR5 publication-title: Breast Cancer Res. Treat. doi: 10.1007/s10549-009-0523-x contributor: fullname: OC Freedman – volume: 100 start-page: 1380 year: 2008 ident: 138_CR4 publication-title: J. Natl. Cancer Inst. doi: 10.1093/jnci/djn309 contributor: fullname: MJ Ellis – volume: 99 start-page: 167 year: 2007 ident: 138_CR3 publication-title: J. Natl. Cancer Inst. doi: 10.1093/jnci/djk020 contributor: fullname: M Dowsett – volume: 9 start-page: 250 year: 2006 ident: 138_CR22 publication-title: Arch. Iran. Med contributor: fullname: M Vasei – volume: 135 start-page: 415 year: 2012 ident: 138_CR31 publication-title: Breast Cancer Res. Treat. doi: 10.1007/s10549-012-2164-8 contributor: fullname: P Kabos – volume: 18 year: 2016 ident: 138_CR15 publication-title: Breast Cancer Res. doi: 10.1186/s13058-016-0696-2 contributor: fullname: E López-Knowles – volume: 2 start-page: pky005 year: 2018 ident: 138_CR16 publication-title: JNCI Cancer Spectr. doi: 10.1093/jncics/pky005 contributor: fullname: Q Gao – volume: 92 start-page: 903 year: 2000 ident: 138_CR6 publication-title: J. Natl. Cancer Inst. doi: 10.1093/jnci/92.11.903 contributor: fullname: JG Klijn – volume: 351 start-page: 1170 year: 1998 ident: 138_CR25 publication-title: Lancet doi: 10.1016/S0140-6736(97)07498-9 contributor: fullname: Z Saad – volume: 72 start-page: 2416 year: 2012 ident: 138_CR30 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-11-3290 contributor: fullname: S Giulianelli – volume: 14 start-page: 962 year: 2003 ident: 138_CR21 publication-title: Ann. Oncol. doi: 10.1093/annonc/mdg258 contributor: fullname: D Coradini – volume: 5 start-page: 182ra55 year: 2013 ident: 138_CR35 publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.3005654 contributor: fullname: T Tanos – volume: 235 start-page: 39 year: 2005 ident: 138_CR48 publication-title: Mol. Cell. Endocrinol. doi: 10.1016/j.mce.2005.01.009 contributor: fullname: S Mrusek – volume: 146 start-page: 515 year: 2014 ident: 138_CR37 publication-title: Breast Cancer Res. Treat. doi: 10.1007/s10549-014-3049-9 contributor: fullname: H Hu – volume: 63 start-page: 800 year: 2010 ident: 138_CR42 publication-title: J. Clin. Pathol. doi: 10.1136/jcp.2010.077578 contributor: fullname: L Zabaglo – volume: 91 start-page: 1854 year: 2001 ident: 138_CR24 publication-title: Cancer doi: 10.1002/1097-0142(20010515)91:10<1854::AID-CNCR1206>3.0.CO;2-Y contributor: fullname: P Pujol – volume: 138 start-page: 157 year: 2013 ident: 138_CR9 publication-title: Breast Cancer Res. Treat. doi: 10.1007/s10549-013-2426-0 contributor: fullname: BP Haynes – volume: 104 start-page: 1762 year: 2011 ident: 138_CR14 publication-title: Br. J. Cancer doi: 10.1038/bjc.2011.145 contributor: fullname: PL Jerevall – volume: 145 start-page: 706 year: 1987 ident: 138_CR28 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/0006-291X(87)91022-9 contributor: fullname: JR Hissom – volume: 351 start-page: 2817 year: 2004 ident: 138_CR11 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa041588 contributor: fullname: S Paik – volume: 18 year: 2016 ident: 138_CR39 publication-title: Breast Cancer Res. doi: 10.1186/s13058-016-0713-5 contributor: fullname: N Simigdala – volume: 49 start-page: 12 year: 2019 ident: 138_CR32 publication-title: Jpn J. Clin. Oncol. doi: 10.1093/jjco/hyy156 contributor: fullname: Y Wanifuchi-Endo – volume: 523 start-page: 313 year: 2015 ident: 138_CR26 publication-title: Nature doi: 10.1038/nature14583 contributor: fullname: H Mohammed – volume: 23 start-page: 5108 year: 2005 ident: 138_CR2 publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2005.04.005 contributor: fullname: I Smith – volume: 49 start-page: 278 year: 2002 ident: 138_CR23 publication-title: Neoplasma. contributor: fullname: C Atalay – volume: 277 start-page: 5209 year: 2002 ident: 138_CR43 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M110090200 contributor: fullname: JK Richer – volume: 15 start-page: 668 year: 2001 ident: 138_CR33 publication-title: Mol. Endocrinol. doi: 10.1210/mend.15.4.0616 contributor: fullname: SC Chapman – volume: 17 start-page: 317 year: 1998 ident: 138_CR20 publication-title: J. Exp. Clin. Cancer Res. contributor: fullname: A Mangia – volume: 27 start-page: 1160 year: 2009 ident: 138_CR12 publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2008.18.1370 contributor: fullname: JS Parker – volume: 114 start-page: 233 year: 2009 ident: 138_CR45 publication-title: Breast Cancer Res. Treat. doi: 10.1007/s10549-008-0003-8 contributor: fullname: CE Wood – volume: 4 start-page: 262 year: 2018 ident: 138_CR1 publication-title: J. Pathol. Clin. Res doi: 10.1002/cjp2.112 contributor: fullname: A Dodson – volume: 10 year: 2008 ident: 138_CR38 publication-title: Breast Cancer Res. doi: 10.1186/bcr2124 contributor: fullname: P Wirapati – volume: 117 start-page: 561 year: 2005 ident: 138_CR47 publication-title: Int. J. Cancer doi: 10.1002/ijc.21186 contributor: fullname: JC Leo – volume: 97 start-page: 4689 year: 2000 ident: 138_CR44 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.080073497 contributor: fullname: RL Robker – volume: 17 start-page: 6012 year: 2011 ident: 138_CR13 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-11-0926 contributor: fullname: M Filipits – volume: 11 start-page: 491 year: 2009 ident: 138_CR7 publication-title: Breast Cancer Res Treat. doi: 10.1007/s10549-008-9949-9 contributor: fullname: MG Jannuzzo – volume: 175 start-page: 349 year: 1984 ident: 138_CR34 publication-title: FEBS Lett. doi: 10.1016/0014-5793(84)80766-8 contributor: fullname: NG Seidah |
SSID | ssj0001468951 |
Score | 2.200898 |
Snippet | Abstract
The major changes in hormone levels that occur through the menstrual cycle have been postulated to affect the expression of hormone-regulated and... The major changes in hormone levels that occur through the menstrual cycle have been postulated to affect the expression of hormone-regulated and... |
SourceID | pubmedcentral proquest crossref |
SourceType | Open Access Repository Aggregation Database |
StartPage | 1 |
SubjectTerms | Breast cancer Gene expression Menstruation Tumors |
SummonAdditionalLinks | – databaseName: ProQuest_Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LSwMxEB5qBfEiPrG-iOBJWLpuks3uSUQsRagnC70t2TxoL7u1raL_3pl9tPbiZVlIILuTSfJN5psZgDtjTBzr3AW5t2EgBMc3Y9JA-NhqmeMzodjh0Vs8HIvXiZx0YNjGwhCtst0Tq43alobuyPuIQ4SKFXGzdE63AGbVf5x_BFQ_ivysTTGNHdh9iBBWoGaridrctog4QSzRujV50l_SyUVUIqIL4aKPtg-mDdrc5kr-OXwGh3DQoEb2VE_zEXRccQx7o8YvfgKLkasywWIf84M9mG6k7iyrQ3uXbFawKQLUsnBBFcCCTag8jrnvhgtbUJcSv2ZRYgPDrdDN0SJnNa_ry7GcCOwrZkhRFqcwHry8Pw-DpppCYEQoVoEwXnDKPqeVTHUqvbZo-qVW0TFuTCQs5wgIrHDCIAhwTqMlx72UXOtQ-ZCfQbfAbzwHlgvpPIIzo6xEwSLI8L6qXJ2nDk3IpAf3rSizeZ00I6uc3TzJarlnKPeM5J5FPbhqhZ0162eZbWa7B7frZtR8cmfowpWfVR_8E7Rvwx6orUlaD0q5s7dbitm0yqFNafc55xf_D34J-xFpCNH-5BV0cSLdNYKQVX5T6dcvo_HgXw priority: 102 providerName: ProQuest |
Title | Menstrual cycle associated changes in hormone-related gene expression in oestrogen receptor positive breast cancer |
URI | https://www.proquest.com/docview/2314767016/abstract/ https://search.proquest.com/docview/2317595490 https://pubmed.ncbi.nlm.nih.gov/PMC6858333 |
Volume | 5 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS8MwED90gvgifuL8GBF8EurKkjTto4pjCBtDFPZW0jRhA-3GNkX_e-_Sdm6vvpRCrjTNXXu_a353B3BjjIkindkgc3kYCMHxzJgkEC7KtczwGFPucH8Q9d7E80iOtkDWuTCetG-yyV3x_nFXTMaeWzn7MO2aJ9Ye9h-pZjrnvL0N24rztRDd_1gRUYywod7B5HF7QU6KWEPEDML3mzrYkNsUEfWSWXdHfxhzkyG55nK6B7BfYUV2X87pELZscQS7_Wo3_Bjmfevrv6KM-UEJpqu1tjkrE3oXbFKwMcLSaWEDn7aCQ2gyltnvigFbkMgUZzOf4gDDD6CdYRzOSjbXl2UZ0daXzJB5zE_grfv0-tgLqh4KgRGhWAbCOMGp5pxWMtGJdDrHgC_JFTlvYzoi5xxhQC6sMOj6rdUYv3EnJdc6VC7kp9AocI5nwDIhrUNIZlSOSxcjtHDO96vOEouBY9yE23op01lZKiP1W9w8TksVpKiClFSQdppwWS92Wr01ixSxplCRQhTahOvVMNo7bWLowk4_vQw-CUa1YRPUhpJWN6WK2ZsjaEi-cnZlOOf_vvIC9jpkR8QDlJfQQB3bK0Qly6yFtjhSLdh5eBoMX1o-tm95y_wFDHHpKQ |
link.rule.ids | 230,315,733,786,790,870,891,12083,21416,27957,27958,31754,31755,33779,33780,43345,43840,53827,53829,74102,74659 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8QwEB58gHoRn7g-I3gSimWTNO1JRJT1sZ4U9hbSPNBLu-6uov_emTbruhcvpZCBtJNJ5pvMlwnAmbU2y0zpkzK4NBGC45u1RSJC5ows8ZnT2eH-U9Z7EfcDOYgbbuNIq5yuic1C7WpLe-QXiEOEyhQilMvhe0K3RlF2NV6hsQjLgnNBlD41ULM9FpHliCCmyUyeX4zJXxGBiEhCONW78-5ohjHnGZJ_XM7tBqxHrMiu2sHdhAVfbcFKP2bDt2HU9039V5Sx3yjBTNS1d6w90DtmbxV7RVhaVz5pjq1gE5qMZ_4rMmArEqnxa0Y1NjBcAP0Q43DWsrk-PSuJtj5hlsxjtAMvtzfP170k3qGQWJGKSSJsEJxqzhklC1PIYBwGfIVT5Lyt7QrHOcIAJ7yw6Pq9Nxi_8SAlNyZVIeW7sFThN-4BK4X0ASGZVU6iYhFahNDcV10WHgPHvAPnU1XqYVsqQzcpbp7rVu8a9a5J77rbgcOpsnWcNWM9G-MOnP42o71TEsNUvv5oZPBPMKpNO6DmBum3U6qYPd9Svb02lbOp2D7nfP__zk9gtffcf9SPd08PB7DWJWsh4p88hCUcVH-EMGRSHje29gOZMd-S |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ZSwMxEB48QHwRT6xnBJ-ExaVJ9ngSr-LVIqLgW8jmoL7s1raK_ntndlNrX3xZFhLI7mSS-SbzZQbg2BiTJLpwUeFtHAnB8c2YPBI-sVoW-Mzo7nC3l9y8iLtX-Rr4T6NAq5zsifVGbStDZ-SniENEmqTEzfKBFvF41TkbvEdUQYoiraGcxjwspiKRqOGLF9e9x6fpiYtIMsQTk9Amz05HZL2ITkSUIVz47VnjNEWcs3zJPwaosworATmy82aq12DOleuw1A2x8Q0Ydl2dDRb7mG_swXSQvLOsud47Ym8l6yNIrUoX1ZdYsAkVyDH3FfiwJXWp8GuGFTYw3A7dAL1y1nC7Ph0riMQ-ZoaUZbgJL53r58ubKFRUiIyIxTgSxgtOGeh0KnOdS68tun-5TcmUG9MWlnMEBVY4YRAIOKfRm-NeSq51nPqYb8FCid-4DawQ0nkEaCa1EgWLQMP7unp1kTt0I7MWnExEqQZN4gxVB7x5phq5K5S7Irmrdgv2JsJWYQ2N1HTGW3D024zaTyENXbrqo-6Df4I-btyCdGaSfgel_NmzLeVbv86jTan3Oec7_w9-CEuoaOrhtne_C8ttUhZiAco9WMA5dfuIScbFQVC2H7XV5TU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Menstrual+cycle+associated+changes+in+hormone-related+gene+expression+in+oestrogen+receptor+positive+breast+cancer&rft.jtitle=NPJ+breast+cancer&rft.au=Haynes%2C+Ben+P&rft.au=Ginsburg%2C+Ophira&rft.au=Gao%2C+Qiong&rft.au=Folkerd%2C+Elizabeth&rft.date=2019-11-15&rft.issn=2374-4677&rft.eissn=2374-4677&rft.volume=5&rft.spage=42&rft.epage=42&rft_id=info:doi/10.1038%2Fs41523-019-0138-2&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2374-4677&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2374-4677&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2374-4677&client=summon |